On July 9, 2026, the Lianchuang & VRN Medical Mid‑year Summary Conference was successfully held. Centered on the theme “Embrace Change, Pursue Innovation; Act with Resolve, Journey Far Ahead”, the conference comprehensively reviewed the steady business achievements of the first half‑year, conducted in‑depth analysis of industry trends, and defined the development roadmap for the second half‑year as well as full‑year sprint targets.
Refined Operations, Synergistic Growth
Heads of each business segment took the floor in turn. They reviewed the operating achievements of the first half‑year, analyzed industry opportunities and existing challenges, and elaborated on overall work philosophies and concrete initiatives for the second half‑year based on full‑year objectives.
Xie Wenjun, Deputy General Manager of E‑commerce BU; Shao Huanqiang, Deputy Sales Director of E‑commerce BU; Li Ningyu, Live‑stream Operations Supervisor of E‑commerce BU; and Li Hui, Sales Administration Director of E‑commerce BU, delivered special reports on the omni‑channel e‑commerce business respectively. The team reviewed channel achievements of the first half‑year, and clarified that it would strengthen the synergy between shelf‑based sales and live‑streaming in the second half‑year, driving online business growth through refined operations and digital empowerment.
Deepen Global Presence, Advance Co‑construction
Wang Hui, Deputy General Manager of VRN Medical Marketing & Director of Marketing Department, delivered a summary and plan for international sales and marketing businesses. She reviewed overseas market achievements and specified that the team would deepen presence in key regions and drive brand localization in the second half‑year. Zhou Tao, Director of VRN Medical International Sales Department, shared benchmark cases and key projects. He proposed to continuously deepen overseas channel cooperation through key‑customer support and clinical co‑construction.
Solidify Channels, Empower through Academia
Zhou Yong, Director of VRN Medical Domestic Sales Department, presented summary and plans for domestic sales and marketing operations. He clarified that the second‑half‑year work will focus on deepening academic empowerment and refined customer operations.
Xiong Zhilong, Key‑Account Manager of VRN Medical Domestic Sales Department, focused on clinical business and expert cooperation with public hospitals. He proposed to strengthen clinical academic co‑construction and optimize business processes, so as to continuously enhance the competitiveness of domestic clinical channels.
Grasp the Essentials, Steer the Course
Cui Xuexing, Deputy General Manager of Urit Lianchuang BU & Director of Marketing Department, and Deputy General Manager of VRN Medical, delivered concluding remarks. He affirmed H1 phased results of each business line, objectively analyzed weaknesses in market competition and business collaboration, and consolidated the team’s development consensus.
Grasping opportunities in the medical device sector, Feng Yun, Executive Deputy General Manager of VRN Medical, focused on digital stomatology and preventive healthcare, setting clear requirements for domestic‑overseas market layout and online‑offline channel integration.
Wang Yan, Executive Vice President of Urit, put forward detailed requirements for business collaboration, risk control management and other dimensions in light of his areas of responsibility, further consolidating standardized safeguards for cross‑departmental cooperation.
Subsequently, Meng Qingshun, Assistant to the President; Professor Shao Liangshan from Liaoning Institute of Technology; and Tang Feng, Chairman of Guilin Measuring & Cutting Tool Co., Ltd., offered highly constructive guidance by examining industry trends and corporate empowerment from multiple perspectives.
Lastly, Shi Ping, President of Urit Group, emphasized that all colleagues should stay aligned with the conference theme and seize opportunities brought by digital‑intelligent transformation. Guided by customer value, the group will deepen product innovation and strengthen business collaboration. Moving forward, it will continue to increase investment in industry‑education integration, talent recruitment and development, global layout and ESG development. With the combined force of down‑to‑earth efforts, the enterprise will be driven toward high‑quality development.
Unite as One, Win the Year
At the closing of the conference, heads of all departments took the stage for a sales‑target commitment ceremony. Holding golden wheat ears — an auspicious symbol of booming sales performance — everyone present made a joint vow to strive for key breakthroughs in the second half‑year.
Guilin Veirun Medical Technology Co., Ltd.
D-07 Information Industrial Park, National High-Tech Zone, Guilin, Guangxi 541004 P. R. China
Tel: +86（773）5880619 / +86（773）2260566
info@veirun.com / service@veirun.com
桂ICP备20001633号 桂公网安备45030502000961号 桂网药服备字[2026]第00061号